Psychedelic medicine: from ceremony to a $10 billion market.
Global psychedelic-medicine market: $10 billion by 2027-28
The proof is in: 1 dose of psilocybin lifts well-being for a year in landmark studies, MDMA therapy took most PTSD patients below the diagnosis line in final-phase trials, cannabis already delivered an FDA-approved epilepsy medicine
The shift: MDMA, psilocybin, and lab-made variants move from ceremonies to corporate patents, Oregon and Colorado already roll out therapeutic psilocybin, ibogaine is studied for addiction, PTSD, and brain injuries
My warning: big pharma is McDonald's serving hamburgers without owning a cow, it patents molecules, never healing, and at $5,000 to $10,000 a treatment the healing goes to the wealthy while the money races ahead of the guardrails
What started as a movement to heal PTSD, depression, and addiction has become a boardroom land grab. I forecast the global psychedelic-medicine market hits $10 billion by 2027-28, as MDMA, psilocybin, and lab-made variants move from underground ceremonies to corporate patents.
And the science is not the question anymore. A single dose of psilocybin lifted well-being for at least a year in the landmark studies, MDMA-assisted therapy took the majority of PTSD patients in final-phase trials below the diagnosis line, and cannabis already produced an FDA-approved epilepsy medicine. Nature keeps passing their own tests.
So understand who is taking over. Big pharma is McDonald's serving hamburgers without owning a cow: it owns patents, never healing. A mushroom that grows for free is a threat until it becomes a patented molecule at $5,000 to $10,000 per treatment.
This is the same industry that spent decades branding weed and natural remedies gateway drugs while it flooded the world with opioids. There is exactly 1 gateway drug, and it is big pharma: an industry that never found a cure in its life, because cures kill subscriptions.
I do not trust the referees, on the record since the COVID years, when cheap medicines got buried, the science got bought, and I got deplatformed for saying it.
The scoreboard so far: Oregon and Colorado roll out therapeutic psilocybin, the FDA panel rejected Lykos' MDMA treatment in 2024, Usona pushes psilocybin through the final trial phase with breakthrough status.
Psychedelics either transform mental health for millions, or become another patented luxury sold back to the desperate. The money is racing ahead of the guardrails, and I side with the millions.
Early call
